BioCentury
ARTICLE | Clinical News

BetaKine: National Cancer Institute filed an IND

October 31, 1994 8:00 AM UTC

Celtrix Pharmaceuticals Inc. (CTRX) Product: BetaKine (TGF-beta-2) Indication: Oral mucositis, a side effect of cytotoxic cancer chemotherapy Status: National Cancer Institute filed an IND ...